SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending due to a newly announced $14 billion deal with Meta to provide computing power for AI infrastructure, fueling discussions about the increasing demand for AI capabilities. Community members are highlighting the significance of this deal, CoreWeave's partnership with Nvidia, and potential future partnerships. Some traders are monitoring price action, while others are focused on long-term bullish prospects in the AI sector.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

$WOLF is trending due to volatility following its bankruptcy exit and share restructuring, leading to a dramatically reduced float and high short interest. The community is discussing the potential for a massive short squeeze, comparing it to $AIFU and $GME, while also expressing confusion and frustration over share conversions. Some traders are filing complaints with the SEC, while others see an opportunity for gains.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending after announcing multiple AI partnerships with tech giants like NVIDIA, OpenAI, Google (Gemini), and Snowflake, sparking excitement about its leadership in agentic AI. The community is buzzing about a potential short squeeze given the high short interest and potential for a run similar to $CRWV or $PLTR, while also debating the impact of the CEO's ongoing stock sales and comparing PATH to competitors like $PLTR.

Draganfly, Inc. engages in the manufacture and sale of commercial unmanned aerial vehicle systems and software serving the public safety, agriculture, industrial inspections, security, mapping, and surveying markets. Its products include quad-copters, fixed wing aircrafts, ground based robots, hand held controllers, and software used for tracking, live streaming, and data collection. The firm also offers custom engineering, training, simulation consulting, as well as data and flight training services. The company was founded by Zenon Dragan and Christine Dragan in 1998 and is headquartered in Saskatoon, Canada.

Draganfly Inc

Draganfly is trending following news of the U.S. Army selecting the company to supply drone systems and support manufacturing at overseas military facilities, which the community views as a major long-term opportunity. Discussions also revolve around the potential size of the Army contract and the possibility of a short squeeze, while some traders caution about potential offerings. Bullish sentiment is high, with some anticipating substantial gains for the drone stock.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending as CoreWeave ($CRWV) secured a massive deal to provide computing power for its AI infrastructure, sparking excitement among bulls.  The community is discussing the deal's implications for the AI race and META's potential growth, while analysts are also weighing in with positive ratings. The news highlights the significant investments being made in AI and META's continued focus on the sector.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology is trending following news of a partnership with Call2Recycle to expand lithium-ion battery recycling. Community members are speculating about the potential release of a Pre-Feasibility Study (PFS) and its impact on the stock, while also noting the company's inclusion in the materials sector and potential government support.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is trending amid discussions about a potential MS upgrade and overall bullish sentiment. Community members are pointing to a cup and handle pattern and Pepsi's distribution network as potential catalysts.  Some traders express frustration with recent price action while others see it as a buying opportunity before earnings.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending due to controversy surrounding an FDA official's retracted LinkedIn post questioning the clinical benefit of their lupus drug, Lupkynis, sparking a significant selloff. The community is discussing potential motivations behind the post, ranging from personal vendettas to market manipulation, and speculating on possible legal action. While Jefferies defends the drug, the incident has intensified existing concerns about leadership and future prospects.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

CRCL is trending as the community discusses its partnerships with Visa and Deutsche Börse, which aim to expand stablecoin adoption for cross-border payments and European financial infrastructure. While some express concerns over the concreteness of these agreements, others highlight positive technical setups and potential breakouts. Community members are actively discussing entry points and potential ROI.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending due to recent data highlighting the potential of oral blarcamesine in treating Alzheimer's, particularly for APOE4 carriers excluded from other trials. The community is discussing the significance of the new data and its implications for regulatory approval, with some expressing frustration over the stock's perceived undervaluation and market manipulation. Despite some skepticism, there's optimism surrounding the drug's potential as a disease-modifying treatment with a favorable safety profile.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

USNA vs. STVN: Which Stock Is the Better Value Option?

Stevanato (STVN) Upgraded to Buy: Here's What You Should Know

Stevanato (STVN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

USNA or STVN: Which Is the Better Value Stock Right Now?

Stevanato Group (STVN) Q2 Earnings and Revenues Beat Estimates

Stevanato (STVN) delivered earnings and revenue surprises of +9.09% and +4.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Stevanato Group (STVN) Earnings Expected to Grow: Should You Buy?

Stevanato (STVN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MKKGY or STVN: Which Is the Better Value Stock Right Now?

MKKGY vs. STVN: Which Stock Is the Better Value Option?

Stevanato (STVN) Soars 10.0%: Is Further Upside Left in the Stock?

Stevanato (STVN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Will Escalating Medical Costs Dampen Centene's Q2 Earnings?

CNC's Q2 earnings are likely to have felt the pinch as rising medical costs pressure margins despite higher premium revenues.

CPRX or STVN: Which Is the Better Value Stock Right Now?

CPRX vs. STVN: Which Stock Is the Better Value Option?

Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.

Stevanato Group Spa

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Current Price	$25.49
Prev Close	$25.66
Open	$25.83
Dividend Yield	0.28%
50-Day Moving Average	$24.55
Beta	0.84
Avg. Volume	351,408.67
PE Ratio	47.61

52-Week High	$28.00
52-Week Low	$17.12
Market Capitalization	$6.96B
EPS (Annual)	$0.4699
Price to Book	4.24
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

STVN
Stevanato Group Spa

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest STVN News

STVN Stevanato Group Spa